Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wandini Lutchmun

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMC Public Health|August 22, 2022
Chronic diseases and multi-morbidity in persons experiencing homelessness: results from a cross-sectional study conducted at three humanitarian clinics in Germany in 2020Wandini Lutchmun, Janina Gach, Christiane Borup, et al.
Clinical and Experimental Dermatology|May 30, 2025
Infectious diseaseEmma Porter, Wandini Lutchmun, Hanne-Brit Smethurst, et al.
Breathe (Sheffield, England)|March 19, 2025
The importance of getting the dose right in the treatment of tuberculosisAndrii Dudnyk, Wandini Lutchmun, Raquel Duarte, et al.
BMC Psychiatry|April 19, 2023
Mental health of people with limited access to health services: a retrospective study of patients attending a humanitarian clinic network in Germany in 2021Kashung Annie Mugambwa, Wandini Lutchmun, Janina Gach, et al.
Jac-Antimicrobial Resistance|August 20, 2025
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of TuberculosisWandini Lutchmun, Norbert Heinrich, Elin M Svensson, et al.
BMC Proceedings|October 14, 2021
Proceedings from the CIH-LMU 2021 Symposium: "Global Health Perspectives: Climate Change & Migration"Wandini Lutchmun, Aikins Ablorde, Han-Wen Chang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Public Health|August 22, 2022
Chronic diseases and multi-morbidity in persons experiencing homelessness: results from a cross-sectional study conducted at three humanitarian clinics in Germany in 2020Wandini Lutchmun, Janina Gach, Christiane Borup, et al.
Clinical and Experimental Dermatology|May 30, 2025
Infectious diseaseEmma Porter, Wandini Lutchmun, Hanne-Brit Smethurst, et al.
Breathe (Sheffield, England)|March 19, 2025
The importance of getting the dose right in the treatment of tuberculosisAndrii Dudnyk, Wandini Lutchmun, Raquel Duarte, et al.
BMC Psychiatry|April 19, 2023
Mental health of people with limited access to health services: a retrospective study of patients attending a humanitarian clinic network in Germany in 2021Kashung Annie Mugambwa, Wandini Lutchmun, Janina Gach, et al.
Jac-Antimicrobial Resistance|August 20, 2025
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of TuberculosisWandini Lutchmun, Norbert Heinrich, Elin M Svensson, et al.
BMC Proceedings|October 14, 2021
Proceedings from the CIH-LMU 2021 Symposium: "Global Health Perspectives: Climate Change & Migration"Wandini Lutchmun, Aikins Ablorde, Han-Wen Chang, et al.
Pageof 1